CDMO Ajinomoto Althea Opens New High Potency and Fill/Finish Facility
Ajinomoto Althea, a San Diego, California-headquartered contract development and manufacturing organization, has opened a new antibody drug conjugate and highly potent fill/finish facility near its existing campus in San Diego.
The manufacturing facility includes areas dedicated to bioconjugation, formulation, purification, quality control, and sterile fill and finish including lyophilization. The 57,000-square-foot facility allows Ajinomoto Althea to offer clients a manufacturing supply chain service from a single US-based location. The facility can accommodate early clinical phase through commercially approved programs.
Source: Ajinomoto Althea